These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29274388)

  • 1. IL-21 dependent Granzyme B production of B-cells is decreased in patients with lupus nephritis.
    Rabani M; Wilde B; Hübbers K; Xu S; Kribben A; Witzke O; Dolff S
    Clin Immunol; 2018 Mar; 188():45-51. PubMed ID: 29274388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
    Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
    Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.
    Dolff S; Quandt D; Wilde B; Feldkamp T; Hua F; Cai X; Specker C; Kribben A; Kallenberg CG; Witzke O
    Arthritis Res Ther; 2010; 12(4):R150. PubMed ID: 20653937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B.
    Hagn M; Ebel V; Sontheimer K; Schwesinger E; Lunov O; Beyer T; Fabricius D; Barth TF; Viardot A; Stilgenbauer S; Hepp J; Scharffetter-Kochanek K; Simmet T; Jahrsdörfer B
    Eur J Immunol; 2010 Jul; 40(7):2060-9. PubMed ID: 20394077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
    Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
    J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus.
    Mitoma H; Horiuchi T; Kimoto Y; Tsukamoto H; Uchino A; Tamimoto Y; Miyagi Y; Harada M
    Int J Mol Med; 2005 Oct; 16(4):609-15. PubMed ID: 16142394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus.
    Zhao LD; Liang D; Wu XN; Li Y; Niu JW; Zhou C; Wang L; Chen H; Zheng WJ; Fei YY; Tang FL; Li YZ; Zhang FC; He W; Cao XT; Zhang X
    Cell Mol Immunol; 2017 Oct; 14(10):842-849. PubMed ID: 27665947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients.
    Heinemann K; Wilde B; Hoerning A; Tebbe B; Kribben A; Witzke O; Dolff S
    Scand J Rheumatol; 2016 Jul; 45(4):312-6. PubMed ID: 26948375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus.
    Yoshikawa M; Nakayamada S; Kubo S; Nawata A; Kitanaga Y; Iwata S; Sakata K; Ma X; Wang SP; Nakano K; Saito K; Tanaka Y
    Clin Immunol; 2019 Mar; 200():1-9. PubMed ID: 30576845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
    Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The abnormality of FcgammaRIIB1-mediated signaling and the hyperactivity of B cells from patients with systemic lupus erythematosus].
    Peng KJ; Xiao LS; Fei Y; Wang SR
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov; 22(6):769-71. PubMed ID: 17077019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD19
    Xiong H; Tang Z; Xu Y; Shi Z; Guo Z; Liu X; Tan G; Ai X; Guo Q
    Adv Rheumatol; 2022 Dec; 62(1):48. PubMed ID: 36494762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-10 receptor expression and signalling were down-regulated in CD4⁺ T cells of lupus nephritis patients.
    Cui HD; Qi ZM; Yang LL; Qi L; Zhang N; Zhang XL; Du SY; Jiang Y
    Clin Exp Immunol; 2011 Aug; 165(2):163-71. PubMed ID: 21635228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased IL-21 Expression Induces Granzyme B in Peripheral CD5(+) B Cells as a Potential Counter-Regulatory Effect in Primary Sjögren's Syndrome.
    Papp G; Gyimesi E; Szabó K; Zöld É; Zeher M
    Mediators Inflamm; 2016; 2016():4328372. PubMed ID: 26884645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regulatory role for CD72 expression on B cells in systemic lupus erythematosus.
    Vadasz Z; Haj T; Balbir A; Peri R; Rosner I; Slobodin G; Kessel A; Toubi E
    Semin Arthritis Rheum; 2014 Jun; 43(6):767-71. PubMed ID: 24461079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis.
    Xia LP; Li BF; Shen H; Lu J
    Scand J Rheumatol; 2015 May; 44(3):200-5. PubMed ID: 25562331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired granzyme B-producing regulatory B cells in systemic lupus erythematosus.
    Bai M; Xu L; Zhu H; Xue J; Liu T; Sun F; Yao H; Zhao Z; Wang Z; Yao R; Hu F; Su Y
    Mol Immunol; 2021 Dec; 140():217-224. PubMed ID: 34749262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.